Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study - Neo-HAT Study

NCT02371330 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02371330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study - Neo-HAT Study
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
September 30, 2017
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia